Scarica l'app Stockscreener
13.60
1.02%
-0.14
Dopo l'orario di chiusura:
13.60
Precedente Chiudi:
$13.74
Aprire:
$14
Volume 24 ore:
299.06K
Relative Volume:
2.49
Capitalizzazione di mercato:
$595.64M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-4.56%
1M Prestazione:
-9.63%
6M Prestazione:
+20.14%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$13.16
$14.56
Intervallo di 1 settimana:
$12.89
$14.56
Portata 52W:
$6.71
$18.67
Maze Therapeutics Inc Stock (MAZE) Company Profile
Nome
Maze Therapeutics Inc
Settore
Industria
Telefono
(650) 850-5070
Indirizzo
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Confronta MAZE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MAZE
Maze Therapeutics Inc
|
13.60 | 601.77M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-23 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-08 | Iniziato | Wedbush | Outperform |
Maze Therapeutics Inc Borsa (MAZE) Ultime notizie
Maze Therapeutics reports Q2 EPS (77c), consensus ($1.15) - MSN
Maze Therapeutics, Inc.: Buy Rating Backed by Promising Clinical Developments and Strategic Trials - TipRanks
What’s the recovery path for long term holders of Maze Therapeutics Inc.Quarterly Portfolio Summary & Weekly High Return Stock Opportunities - Newser
Maze Therapeutics: Promising Innovations in PKU and CKD Treatment with MZE782 - TipRanks
Risk adjusted return profile for Maze Therapeutics Inc. analyzedWeekly Stock Recap & Consistent Growth Equity Picks - Newser
Should you wait for a breakout in Maze Therapeutics Inc.Oil Prices & High Return Trade Opportunity Guides - Newser
How Maze Therapeutics Inc. stock performs during market volatility2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Why Maze Therapeutics Inc. stock attracts strong analyst attentionQuarterly Trade Review & Risk Controlled Daily Plans - Newser
Using data models to predict Maze Therapeutics Inc. stock movement - Newser
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights - GlobeNewswire
How to escape a deep drawdown in Maze Therapeutics Inc.Free Real Market Momentum Signal Generator - Newser
Is it time to cut losses on Maze Therapeutics Inc.Free Fast Gaining Stock Screener Report - Newser
Will Maze Therapeutics Inc. stock recover after earningsExploding Volume High ROI Picks - newsyoung.net
Institutional scanner results for Maze Therapeutics Inc.Free Buy Alerts With Low Risk Confirmation - Newser
When is the best time to exit Maze Therapeutics Inc.Technical Chart Summary for Momentum Stocks - Newser
Published on: 2025-08-12 08:41:52 - Newser
Will a bounce in Maze Therapeutics Inc. offer an exitBuy and Hold Strategy for Capital Safety - Newser
What moving averages say about Maze Therapeutics Inc.Profit Target Planning with Exit Confidence - Newser
How to build a custom watchlist for Maze Therapeutics Inc.Real Market Tracker with Price Action Tools - Newser
What makes Maze Therapeutics Inc. stock price move sharplyStock Entry Point Planner with Volume Spike - Newser
Visual trend scoring systems applied to Maze Therapeutics Inc.Portfolio Risk Distribution Analysis Tool - Newser
Real time pattern detection on Maze Therapeutics Inc. stockFree Risk-Adjusted Picks With Exit Strategy - Newser
Bank of New York Mellon Corp Makes New Investment in Maze Therapeutics, Inc. (NASDAQ:MAZE) - Defense World
Maze Therapeutics, Inc. (NASDAQ:MAZE) Receives $25.60 Average Price Target from Analysts - Defense World
How does Maze Therapeutics Inc. compare to its industry peersFast-track wealth growth - Jammu Links News
What are the technical indicators suggesting about Maze Therapeutics Inc.Invest confidently with real-time market updates - Jammu Links News
How volatile is Maze Therapeutics Inc. stock compared to the marketDiscover top stock picks for aggressive growth - Jammu Links News
What institutional investors are buying Maze Therapeutics Inc. stockFree Stock Market Forecast Reports - Jammu Links News
What are analysts’ price targets for Maze Therapeutics Inc. in the next 12 monthsInvest confidently with advanced analysis tools - Jammu Links News
What drives Maze Therapeutics Inc. stock priceCapitalize on emerging market opportunities - Jammu Links News
Is Maze Therapeutics Inc. a growth stock or a value stockBuild wealth steadily with proven stock picks - Jammu Links News
Is Maze Therapeutics Inc. stock overvalued or undervaluedUnlock exclusive stock market insights - Jammu Links News
Is Maze Therapeutics Inc. stock poised for growthFree Alpha Driven Watchlist With Alerts - Newser
Why is Maze Therapeutics Inc. stock attracting strong analyst attentionUnmatched profit potential - Jammu Links News
What are the latest earnings results for Maze Therapeutics Inc.High-profit capital plays - Jammu Links News
Maze Therapeutics Inc Azioni (MAZE) Dati Finanziari
Non sono disponibili dati finanziari per Maze Therapeutics Inc (MAZE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):